Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
If you are 3079 years old, talk to your clinician about getting your PREVENT score calculated
[56] [57] Economic evaluations of GLP-1 receptor agonists for non-diabetic obesity have reported incremental cost-effectiveness ratios well above common willingness-to-pay thresholds, including estimates in the approximate range of $237,000-$483,000 per quality-adjusted life-year in some U.S.-based models
Klibanov, A
& Mathieu, C
US$ 23.93
US$ 28.14
US$ 22.81
US$ 20.66
US$ 28.06
US$ 25.86
